CARLA HALE: Open Payments
NPI 1154315430 · GLASGOW, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,184 in 66 payments from 16 companies in 2025. Trend: 2023 $1,156 · 2024 $1,311 · 2025 $1,184
Food & beverage: $1,184
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $176 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $167 |
| ABBVIE INC. | 5 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $100 |
| PFIZER INC. | 4 | $86 |
| Viatris Specialty LLC | 5 | $85 |
| GlaxoSmithKline, LLC. | 5 | $84 |
| Lilly USA, LLC | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
Products named: JARDIANCE, Kerendia, OTEZLA, ELIQUIS, YUPELRI, TRELEGY ELLIPTA, EVENITY, MOUNJARO.
Industry payments across KY — which companies pay providers there.
